Abstract
Anaplastic lymphoma kinase (ALK)/epidermal growth factor receptor (EGFR) co-alterations in adenocarcinomas are rare and no therapeutic consensus is re......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
